(Q35666332)

English

MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib

scientific article published on 31 October 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

11

object named as

Ravi Salgia

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

10

object named as

Daniel A Haber

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

12

object named as

Yung-Jue Bang

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Kristin Bergethon

6

object named as

Kristin Bergethon

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

15

object named as

A John Iafrate

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

9

object named as

Keith D Wilner

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

2

object named as

Eunice L Kwak

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Jeffrey W Clark

13

object named as

Jeffrey W Clark

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Benjamin J Solomon

14

object named as

Benjamin J Solomon

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

James G Christensen

8

object named as

James G Christensen

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

author name string

Jochen K Lennerz

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Allison Ackerman

3

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Michael Michael

4

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Gregory Y Lauwers

7

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

language of work or name

0 references

publication date

31 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

36

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

4803-4810

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

MET expression and amplification in patients with localized gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

12 July 2018

Multiple mutations and bypass mechanisms can contribute to development of acquired resistance to MET inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

12 July 2018

MET and KRAS gene amplification mediates acquired resistance to MET tyrosine kinase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

12 July 2018

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

12 July 2018

Phase II study of sorafenib in combination with docetaxel and cisplatin in the treatment of metastatic or advanced gastric and gastroesophageal junction adenocarcinoma: ECOG 5203.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

12 July 2018

Role of c-Met in cancer: emphasis on lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

12 July 2018

An update on biochemotherapy of advanced gastric and gastroesophageal adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

12 July 2018

Combined modality therapy of esophageal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

12 July 2018

Drug development of MET inhibitors: targeting oncogene addiction and expedience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

12 July 2018

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

12 July 2018

EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

12 July 2018

Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

12 July 2018

An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

12 July 2018

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

12 July 2018

Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

12 July 2018

The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

12 July 2018

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

12 July 2018

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

12 July 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

12 July 2018

Adenocarcinoma of the gastroesophageal junction in Japan: relevance of Siewert's classification applied to 177 cases resected at a single institution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

12 July 2018

Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage, and Helicobacter pylori infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

12 July 2018

Frequent amplification of the c-met gene in scirrhous type stomach cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

12 July 2018

Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

25 September 2018

Gastric cardiac carcinomas involving the esophagus are more adequately staged as gastric cancers by the 7th edition of the American Joint Commission on Cancer Staging System

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

25 September 2018

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for advanced esophagogastric cancer: dose-finding study for the prospective multicenter, randomized, phase II/III REAL-3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

25 September 2018

Adenocarcinomas on the rise--does it influence survival from oesophageal cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

25 September 2018

Esophagogastric junction adenocarcinoma according to Siewert classification in Taiwan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

25 September 2018

Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

25 September 2018

Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

25 September 2018

Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

25 September 2018

Overexpression of c-erb-B2 proteins in tumor and non-tumor parts of gastric adenocarcinoma--emphasis on its relation to H. pylori infection and clinicohistological characteristics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

25 September 2018

Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3255989

25 September 2018

Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042947

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042947

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A proposal for diagnostically meaningful criteria to classify increased epidermal growth factor receptor and c-erbB-2 gene copy numbers in gastric carcinoma, based on correlation of fluorescence in situ hybridization and immunohistochemical measurem

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042947

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042947

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose and schedule study of panitumumab monotherapy in patients with advanced solid malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042947

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042947

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene amplification in gastric and esophageal adenocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042947

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amplification of epidermal growth factor receptor gene and its relationship to survival in human gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042947

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical evaluation of a panel of tumor cell markers during malignant progression in Barrett esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042947

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastroesophageal cancers: progress and problems

1 reference

https://pubmed.ncbi.nlm.nih.gov/22042947

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2011.35.4928

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35666332&oldid=2081561896"